August 16, 2019
Authored and Edited by Nicholas J. Doyle; Samhitha Muralidhar Medatia; Elizabeth D. Ferrill
In Celgene Corp. v. Peter, Nos. 2018-1167, 2018-1168, 2018-1169, 2018-1171 (Fed. Cir. July 30, 2019), the Federal Circuit had an opportunity to address a situation that was explicitly noted by the Supreme Court in Oil States: retroactively applying AIA procedures, such as IPR, to pre-AIA patents. Specifically, was the PTO committing an unconstitutional taking when it finds a pre-AIA patent invalid in an IPR? The Federal Circuit answered no.
After affirming the PTAB’s decision that certain claims of two particular pre-AIA patents were obvious, Chief Judge Prost and Judges Bryson and Reyna unanimously held that the retroactive application of IPRs to pre-AIA patents is not an unconstitutional taking. The Court arrived at this conclusion largely by comparing IPRs to pre-AIA review mechanisms, such as ex parte and inter partes reexaminations, to see if they differed in substance or procedure enough to amount to a taking. The Court concluded that they did not. While IPRs and reexaminations differ in some ways, the Federal Circuit reasoned that the mechanisms share the same grounds for review, standard of proof, claim construction standard, and purpose. Further, the Director of the PTO has the same discretion to initiate IPRs as he or she did in initiating reexaminations.
The Court compared these similarities to the differences—that IPRs are adjudicative and have discovery, briefing, and an oral hearing—and concluded that the PTO did not commit an unconstitutional taking in applying IPRs to pre-AIA patents.
Copyright © 2019 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.